Showing 34,848 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Resistance

The cornerstone of HIV treatment may be losing some of its power: will dolutegravir resistance become a problem?

News
12 March 2024
PrEP programmes & uptake

Mixed Digital Intervention Increases HIV Prevention Adherence in Young People

Editor's pick
Infectious Disease Advisor
12 March 2024
Injectable & long-acting PrEP

Ultra-long-acting cabotegravir could be taken three times a year for HIV PrEP and treatment

News
12 March 2024
Activism & civil society

Iconic LGBTQ and AIDS activist David Mixner dies at 77

Editor's pick
Washington Blade
12 March 2024
Epidemiology

UNAIDS calls for collective responsibility and community support to address Fiji’s growing HIV epidemic

Editor's pick
UNAIDS
12 March 2024
Pregnancy and vertical transmission

HIV medication dolutegravir not linked with increased blood pressure during pregnancy

News
11 March 2024
Discrimination & the law

People living with and at risk of acquiring HIV in Northern Ireland deserve equal protection from discrimination

Editor's pick
National AIDS Trust
11 March 2024
Hepatitis & HIV

Researchers encourage simultaneous testing for three viruses-HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV)

Editor's pick
CATIE
11 March 2024
The search for a cure

CROI 2024: HIV remission in children Video

March 2024
Improving HIV care

Improving care of hospitalized patients with HIV in Tanzania

Editor's pick
EurekAlert!
11 March 2024
Menopause

Switch to an integrase inhibitor leads to greater weight during and after the menopause

News
11 March 2024
Women

At the 68th Commission on Status of Women UNAIDS calls for action to achieve gender equality and end AIDS

Editor's pick
UNAIDS
11 March 2024
New & experimental HIV treatments

New Once-Daily HIV Oral Alternative Advances

Editor's pick
Medscape (requires free registration)
9 March 2024
New & experimental HIV treatments

CytoDyn finally clears FDA hold on HIV program after 2 years

Editor's pick
FierceBiotech
8 March 2024
Access to healthcare

British/Mexican man arrested for being gay in Qatar is being denied HIV medications

Editor's pick
LGBTQ Nation
8 March 2024
Combatting stigma

What I Learned From Editing Wikipedia With an HIV-Centric Lens

Editor's pick
TheBody
8 March 2024
Pregnancy and vertical transmission

Community leadership driving progress to eliminate mother-to-child HIV transmission in Indonesia

Editor's pick
UNAIDS
8 March 2024
HIV & criminal law

Singapore: HIV disclosure law to be amended to exempt those with undetectable viral load if conditions are met

Editor's pick
The Straits Times
8 March 2024
HIV prevention policy

Huge increase in PrEP uptake when services offer choice, flexibility and injectable PrEP, African study shows

News
8 March 2024
PrEP science

Far fewer HIV infections in Australian PrEP users – consistent use is key

News
8 March 2024
HIV vaccine & cure research

5 Years After an HIV Cure: “London Patient” and His Physician Look Forward—And Back

Editor's pick
TheBodyPro
8 March 2024
HIV & criminal law

HIV Activist Continues Fight to End Stigma and HIV Criminalization After Incarceration

Editor's pick
TheBody
8 March 2024
HIV & criminal law

Black Men Make Up Almost Half of HIV Crime Cases in Mississippi

Editor's pick
POZ
8 March 2024
Sexually transmitted infections epidemiology

STI cases on the rise across Europe

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
7 March 2024